Employment
BioDiscovery, Inc. is dedicated to the development of state-of-the-art bioinformatics tools for life science research applications. Our mission is to enable scientist to eliminate disease and suffering through novel application of computational technologies.
From our inception, we have been an innovative leader in the microarray informatics area having introduced the first dedicated commercial software tool for analyzing microarray images. Since then, we have continued to make innovations a priority. We look for candidates that are excited about solving difficult problems and enabling scientist to make significant scientific breakthroughs. BioDiscovery is an equal opportunity employer with good benefits, and a friendly, high-energy atmosphere. We are headquartered in sunny Southern California near the Los Angeles International Airport (LAX).
BioDiscovery always seeks candidates of exceptional ability in the areas of software development, support, sales, and applications. To be considered for these or other positions, please forward your resume to careers[at]biodiscovery[dot]com. Use the Requisition Number to the corresponding job in the subject of the email. Submissions without the requisition number will not be considered.
Note: BioDiscovery, Inc. does not accept solicitations from employment agencies, recruiters, or staffing agencies.
Positions Currently Available
Account Manager – Req-BDI009749
Business Development EMEA - Req-BDI009744
Field Application Scientist EMEA – Req-BDI009745
Field Application Scientist (US East) – Req-BDI009746
Field Application Scientist (US West) – Req-BDI009747
Sr. Software Engineer – Req-BDI009750
Search
Recent Publications
Feb. 2012 - LA Forsberg et. al.
Age-related somatic structural changes in the nuclear genome of human blood cells.
READ MOREFeb. 2012 - T Rausch et. al.
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations.
READ MOREJanuary 2012 - C Wu et. al.
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.
READ MORERecent News
BioDiscovery’s Nexus Copy Number 6 Significantly Improves Analysis of Cancer Samples with New ASCAT Processing
EL SEGUNDO, CA, August 31, 2011 - BioDiscovery, Inc. a leader in integrated software solutions for genomics data analysis from high-throughput microarray and Next-Gen sequencing technologies announced today inclusion of the Allele Specific Copy number Ana... Read More
Upcoming Events
BioDiscovery’s Nexus Copy Number 6 Significantly Improves Analysis of Cancer Samples with New ASCAT Processing
EL SEGUNDO, CA, August 31, 2011 - BioDiscovery, Inc. a leader in integrated software solutions for g[...]
BioDiscovery Releases Nexus Copy Number Version 6.0 for DNA Copy Number Analysis and Visualization
BioDiscovery Releases Nexus Copy Number Version 6.0 for DNA Copy Number Analysis and Visualization [...]
Affymetrix selects BioDiscovery as OncoScan™ FFPE Express preferred software provider
Custom Nexus Copy Number™ solution and consulting streamlines difficult cancer sample analysis. E[...]




